04:43 PM EDT, 07/09/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) said Tuesday it plans to offer up to $200 million in common shares and to certain investors pre-funded warrants to purchase common shares in an underwritten public offering.

Underwriters will get a 30-day option to purchase up to $30 million in common shares, according to the company.

IDEAYA said in a separate filing that preliminary estimates show that it had about $952.7 million in cash, cash equivalents and marketable securities as of June 30.

The company's shares were down 4% in recent after-hours activity.

Price: 37.03, Change: -1.58, Percent Change: -4.10